| Product NDC: | 0409-3863 |
| Proprietary Name: | Foscarnet Sodium |
| Non Proprietary Name: | Foscarnet Sodium |
| Active Ingredient(s): | 24 mg/mL & nbsp; Foscarnet Sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0409-3863 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077174 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100707 |
| Package NDC: | 0409-3863-05 |
| Package Description: | 12 BOTTLE, GLASS in 1 CASE (0409-3863-05) > 500 mL in 1 BOTTLE, GLASS |
| NDC Code | 0409-3863-05 |
| Proprietary Name | Foscarnet Sodium |
| Package Description | 12 BOTTLE, GLASS in 1 CASE (0409-3863-05) > 500 mL in 1 BOTTLE, GLASS |
| Product NDC | 0409-3863 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Foscarnet Sodium |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100707 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | FOSCARNET SODIUM |
| Strength Number | 24 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Pyrophosphate Analog [Chemical/Ingredient],Pyrophosphate Analog DNA Polymerase Inhibitor [EPC] |